Role of EDHF in type 2 diabetes-induced endothelial dysfunction

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 295, Issue 5, 2008, Pages

  Park, Yoonjung ^a   Capobianco, Stefano ^a   Gao, Xue ^a   Falck, John R ^b   Dellsperger, Kevin C ^a   Zhang, Cuihua ^a  

^a UNIVERSITY OF MISSOURI   (United States)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

Acetylcholine; Coronary Disease; Endothelium; Endothelium derived hyperpolarizing factor; Inflammation; Microcirculation

Indexed keywords

APAMIN; CALCIUM ACTIVATED POTASSIUM CHANNEL; CATALASE; CELL PROTEIN; CHARYBDOTOXIN; EPOXYICOSATRIENOIC ACID; HYDROGEN PEROXIDE; INDOMETACIN; INTERLEUKIN 6; N(G) NITROARGININE METHYL ESTER; NEUTRALIZING ANTIBODY; OXYGEN; POTASSIUM ION; PROTEIN EDHF; UNCLASSIFIED DRUG; WATER;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CALCIUM CONDUCTANCE; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; FEMALE; INCUBATION TIME; MALE; MOUSE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN SYNTHESIS; RAT; REAL TIME POLYMERASE CHAIN REACTION; VASODILATATION;

ANIMALS; ARTERIOLES; BIOLOGICAL FACTORS; BLOOD GLUCOSE; BODY WEIGHT; CORONARY VESSELS; CYCLOOXYGENASE INHIBITORS; DIABETES MELLITUS, TYPE 2; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FEMALE; HYDROGEN PEROXIDE; INTERLEUKIN-6; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NITRIC OXIDE; NITRIC OXIDE SYNTHASE; POTASSIUM CHANNEL BLOCKERS; POTASSIUM CHANNELS; RNA, MESSENGER; TUMOR NECROSIS FACTOR-ALPHA; VASODILATION; VASODILATOR AGENTS;

EID: 57049119170     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.01261.2007     Document Type: Article

References (41)

1. Anguloa J, Cuevasb P, Fernándezb A, Gabanchoa S, Allonaa A, Martín-Moralesa A, Moncadaa I, Videlac S, Sáenz de Tejada I. Diabetes impairs endothelium-dependent relaxation of human penile vascular tissues mediated by NO and EDHF. Biochem Biophys Res Commun 312: 1202-1208, 2003.
2. + channel in porcine coronary artery endothelium: relevance to EDHF. Br J Pharmacol 135: 1133-1143, 2002.
3. + channel-dependent EDHF responses in Type II diabetic ZDF rats. Br J Pharmacol 148: 434-441, 2006.
4. + channel in porcine coronary endothelium: relevance to EDHF. Br J Pharmacol 137: 1346-1354, 2002.
5. Campbell WB, Harder DR. Endothelium-derived hyperpolarizing factors and vascular cytochrome P450 metabolites of arachidonic acid in the regulation of tone. Circ Res 84: 484-488, 1999.
6. Dandona P, Aljada A, Chaudhuri A, Mohanty P. Endothelial dysfunction, inflammation and diabetes. Rev Endocr Metab Disord 5: 189-197, 2004.
7. De Vriese AS, Verbeuren TJ, Van de Voorde J, Lameire NH, Vanhoutte PM. Endothelial dysfunction in diabetes. Br J Pharmacol 130: 963-974, 2000.
8. Duncan BB, Schmidt MI, Pankow JS, Ballantyne CM, Couper D, Vigo A, Hoogeveen R, Folsom AR, Heiss G. Low-grade systemic inflammation and the development of type 2 diabetes: the atherosclerosis risk in communities study. Diabetes 52: 1799-1805, 2003.
9. + is an endothelium-derived hyperpolarizing factor in rat arteries. Nature 396: 269-272, 1998.
10. Félétou M, Vanhoutte PM. Endothelium-derived hyperpolarizing factor: where are we now? Arterioscler Thromb Vasc Biol 26: 1215-1225, 2006.
11. Félétou M, Vanhoutte PM. The alternative: EDHF. J Mol Cell Cardiol 31: 15-22, 1999.
12. Fitzgerald SM, Kemp-Harper BK, Tare M, Parkington HC. Role of endothelium-derived hyperpolarizing factor in endothelial dysfunction during diabetes. Clin Exp Pharmacol Physiol 32: 482-487, 2005.
13. Fukao M, Hattori Y, Kanno M, Sakuma I, Kitabatake A. Alterations in endothelium-dependent hyperpolarization and relaxation in mesenteric arteries from streptozotocin-induced diabetic rats. Br J Pharmacol 121: 1383-1391, 1997.
14. Furchgott RF, Vanhoutte PM. Endothelium-derived relaxing and contracting factors. FASEB J 3: 2007-2018, 1989.
15. Furchgott RF, Zawadzki JV. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 299: 373-376, 1980.
16. db mice. Circulation 115: 245-254, 2007.
17. Gauthier KM, Deeter C, Krishna UM, Reddy YK, Bondlela M, Falck J, Campbell WB. 14,15-Epoxyeicosa-5(Z)-enoic acid: a selective epoxyeicosatrienoic acid antagonist that inhibits endothelium-dependent hyperpolarization and relaxation in coronary arteries. Circ Res 90: 1028-1036, 2002.
18. Ca in endothelium-dependent hyperpolarizations of the guinea-pig isolated carotid artery. Br J Pharmacol 144: 477-485, 2005.
19. Haddy FJ, Vanhoutte PM, Feletou M. Role of potassium in regulating blood flow and blood pressure. Am J Physiol Regul Integr Comp Physiol 290: R546-R552, 2006.
20. Hecker M. Endothelium-derived hyperpolarizing factor-fact or fiction? News Physiol Sci 15: 1-5, 2000.
21. Klover PJ, Clementi AH, Mooney RA. Interleukin-6 depletion selectively improves hepatic insulin action in obesity. Endocrinology 146: 3417-3427, 2005.
22. Klover PJ, Zimmers TA, Koniaris LG, Mooney RA. Chronic exposure to interleukin-6 causes hepatic insulin resistance in mice. Diabetes 52: 2784-2789, 2003.
23. -ΔΔCT method. Methods 25: 402-408, 2001.
24. Makino A, Ohuchi K, Kamata K. Mechanisms underlying the attenuation of endothelium-dependent vasodilatation in the mesenteric arterial bed of the streptozotocin-induced diabetic rat. Br J Pharmacol 130: 549-556, 2000.
25. Malmsjo M, Bergdahl A, Zhao XH, Sun XY, Hedner T, Edvinsson L, Erlinge D. Enhanced acetylcholine and P2Y-receptor stimulated vascular EDHF-dilatation in congestive heart failure. Cardiovasc Res 43: 200-209, 1999.
26. Matoba T, Shimokawa H, Morikawa K, Kubota H, Kunihiro I, Urakami-Harasawa L, Mukai Y, Hirakawa Y, Akaike T, Takeshita A. Electron spin resonance detection of hydrogen peroxide as an endothelium-derived hyperpolarizing factor in porcine coronary microvessels. Arterioscler Thromb Vasc Biol 23: 1224-1230, 2003.
27. + channels. Circulation 99: 3132-3138, 1999.
28. 2 and prostacyclin. Pharmacol Rev 30: 293-331, 1979.
29. Najibi S, Cowan CL, Palacino JJ, Cohen RA. Enhanced role of potassium channels in relaxations to acetylcholine in hypercholesterolemic rabbit carotid artery. Am J Physiol Heart Circ Physiol 266: H2061-H2067, 1994.
30. Pannirselvam M, Ding H, Anderson TJ, Triggle CR. Pharmacological characteristics of endothelium-derived hyperpolarizing factor-mediated relaxation of small mesenteric arteries from db/db mice. Eur J Pharmacol 551: 98-107, 2006.
31. Picchi A, Gao X, Belmadani S, Potter BJ, Focardi M, Chilian WM, Zhang C. Tumor necrosis factor-alpha induces endothelial dysfunction in the prediabetic metabolic syndrome. Circ Res 99: 69-77, 2006.
32. Pradhan AD, Manson JE, Rifai N, Buring JE, Ridker PM. C-reactive protein, interleukin 6, and risk of developing type 2 diabetes mellitus. JAMA 286: 327-334, 2001.
33. Saitoh S, Zhang C, Tune JD, Potter B, Kiyooka T, Rogers PA, Knudson JD, Dick GM, Swafford A, Chilian WM. Hydrogen peroxide: a feed-forward dilator that couples myocardial metabolism to coronary blood flow. Arterioscler Thromb Vasc Biol 26: 2614-2621, 2006.
34. Shimokawa H, Morikawa K. Hydrogen peroxide is an endothelium-derived hyperpolarizing factor in animals and humans. J Mol Cell Cardiol 39: 725-732, 2005.
35. Shimokawa H, Yasutake H, Fujii K, Owada MK, Nakaike R, Fukumoto Y, Takayanagi T, Nagao T, Egashira K, Fujishima M, Takeshita A. The importance of the hyperpolarizing mechanism increases as the vessel size decreases in endothelium-dependent relaxations in rat mesenteric circulation. J Cardiovasc Pharmacol 28: 703-711, 1996.
36. 2 impairs endothelium-dependent nitric oxide-mediated dilation of coronary arterioles. Arterioscler Thromb Vasc Biol 26: 2035-2042, 2006.
37. Turner NA, Mughal RS, Warburton P, O'regan DJ, Ball SG, Porter KE. Mechanism of TNFalpha-induced IL-1alpha, IL-1beta and IL-6 expression in human cardiac fibroblasts: Effects of statins and thiazolidinediones. Cardiovasc Res 76: 81-90, 2007.
38. Wigg SJ, Tare M, Tonta MA, O'Brien RC, Meredith I, Parkington HC. Comparison of effects of diabetes mellitus on an EDHF-dependent and an EDHF-independent artery. Am J Physiol Heart Circ Physiol 281: H232-H240, 2001.
39. Yada T, Shimokawa H, Hiramatsu O, Kajita T, Shigeto F, Goto M, Ogasawara Y, Kajiya F. Hydrogen peroxide, an endogenous endothelium-derived hyperpolarizing factor, plays an important role in coronary autoregulation in vivo. Circulation 107: 1040-1045, 2003.
40. 2 receptors in modulating coronary microvascular function. Circ Res 92: 322-329, 2003.
41. Zhang C, Xu X, Potter BJ, Wang W, Kuo L, Michael L, Bagby GJ, Chilian WM. TNF-alpha contributes to endothelial dysfunction in ischemia/ reperfusion injury. Arterioscler Thromb Vasc Biol 26: 475-480, 2006.